198 related articles for article (PubMed ID: 20876301)
1. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.
Lai YJ; Lin VT; Zheng Y; Benveniste EN; Lin FT
Mol Cell Biol; 2010 Dec; 30(23):5582-96. PubMed ID: 20876301
[TBL] [Abstract][Full Text] [Related]
2. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
Lai YJ; Lin WC; Lin FT
J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779
[TBL] [Abstract][Full Text] [Related]
3. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
4. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.
Lin VT; Lin FT
Cell Signal; 2011 Nov; 23(11):1691-7. PubMed ID: 21689746
[TBL] [Abstract][Full Text] [Related]
5. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
6. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.
Lai YJ; Chen CS; Lin WC; Lin FT
Mol Cell Biol; 2005 Jul; 25(14):5859-68. PubMed ID: 15988003
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.
E S; Lai YJ; Tsukahara R; Chen CS; Fujiwara Y; Yue J; Yu JH; Guo H; Kihara A; Tigyi G; Lin FT
J Biol Chem; 2009 May; 284(21):14558-71. PubMed ID: 19293149
[TBL] [Abstract][Full Text] [Related]
8. c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.
McMichael BK; Meyer SM; Lee BS
J Biol Chem; 2010 Aug; 285(34):26641-51. PubMed ID: 20547766
[TBL] [Abstract][Full Text] [Related]
9. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
Fei J; Li J; Shen S; Zhou W
Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
[TBL] [Abstract][Full Text] [Related]
10. Supervillin modulation of focal adhesions involving TRIP6/ZRP-1.
Takizawa N; Smith TC; Nebl T; Crowley JL; Palmieri SJ; Lifshitz LM; Ehrhardt AG; Hoffman LM; Beckerle MC; Luna EJ
J Cell Biol; 2006 Jul; 174(3):447-58. PubMed ID: 16880273
[TBL] [Abstract][Full Text] [Related]
11. [Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines].
Gur'ianova OA; Sablina AA; Chumakov PM; Frolova EI
Mol Biol (Mosk); 2005; 39(5):905-9. PubMed ID: 16240724
[TBL] [Abstract][Full Text] [Related]
12. Trip6 promotes dendritic morphogenesis through dephosphorylated GRIP1-dependent myosin VI and F-actin organization.
Lv K; Chen L; Li Y; Li Z; Zheng P; Liu Y; Chen J; Teng J
J Neurosci; 2015 Feb; 35(6):2559-71. PubMed ID: 25673849
[TBL] [Abstract][Full Text] [Related]
13. TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation.
Lin FT; Lin VY; Lin VT; Lin WC
Cell Discov; 2016; 2():15048-. PubMed ID: 27134758
[TBL] [Abstract][Full Text] [Related]
14. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
[TBL] [Abstract][Full Text] [Related]
15. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains.
Wang Y; Gilmore TD
Biochim Biophys Acta; 2001 Apr; 1538(2-3):260-72. PubMed ID: 11336797
[TBL] [Abstract][Full Text] [Related]
16. TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.
Chastre E; Abdessamad M; Kruglov A; Bruyneel E; Bracke M; Di Gioia Y; Beckerle MC; van Roy F; Kotelevets L
FASEB J; 2009 Mar; 23(3):916-28. PubMed ID: 19017743
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of TRIP6 in cell physiology and cancer.
Willier S; Butt E; Richter GH; Burdach S; Grunewald TG
Biol Cell; 2011 Dec; 103(12):573-91. PubMed ID: 22054418
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
Thomas LR; Johnson RL; Reed JC; Thorburn A
J Biol Chem; 2004 Dec; 279(50):52479-86. PubMed ID: 15452120
[TBL] [Abstract][Full Text] [Related]
19. LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor.
Zhao MK; Wang Y; Murphy K; Yi J; Beckerle MC; Gilmore TD
Gene Expr; 1999; 8(4):207-17. PubMed ID: 10794523
[TBL] [Abstract][Full Text] [Related]
20. Engagement of Fas differentially regulates the production of LPS-induced proinflammatory cytokines and type I interferons.
Brennan K; Lyons C; Fernandes P; Doyle S; Houston A; Brint E
FEBS J; 2019 Feb; 286(3):523-535. PubMed ID: 30536547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
